Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
2.850
-0.140 (-4.68%)
At close: Apr 1, 2025, 4:00 PM
2.844
-0.006 (-0.22%)
After-hours: Apr 1, 2025, 5:13 PM EDT

Atea Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
2442832544017433,452
Upgrade
Market Cap Growth
11.19%11.19%-36.48%-46.08%-78.48%-
Upgrade
Enterprise Value
-209-198-338-261-963,522
Upgrade
Last Close Price
2.853.353.054.818.9441.78
Upgrade
PE Ratio
----6.13-
Upgrade
PS Ratio
---2.1170.97
Upgrade
PB Ratio
0.550.650.460.631.056.30
Upgrade
P/TBV Ratio
0.650.650.460.631.056.30
Upgrade
P/FCF Ratio
----11.63
Upgrade
P/OCF Ratio
----11.63
Upgrade
EV/Sales Ratio
----72.42
Upgrade
EV/FCF Ratio
----11.87
Upgrade
Debt / Equity Ratio
0.000.000.000.010-
Upgrade
Debt / EBITDA Ratio
----0.00-
Upgrade
Asset Turnover
----0.430.11
Upgrade
Quick Ratio
24.4424.4418.0435.0013.442.71
Upgrade
Current Ratio
24.8524.8518.2435.7713.582.73
Upgrade
Return on Equity (ROE)
-33.88%-33.88%-22.74%-17.16%19.27%-3.86%
Upgrade
Return on Assets (ROA)
-15.60%-15.60%-11.94%-9.65%10.57%-1.56%
Upgrade
Return on Capital (ROIC)
-16.56%-16.56%-12.54%-10.26%13.75%-2.43%
Upgrade
Return on Capital Employed (ROCE)
----19.30%-
Upgrade
Earnings Yield
-69.08%-59.51%-53.42%-28.93%16.31%-0.32%
Upgrade
FCF Yield
-55.59%-47.89%-33.56%-30.68%-11.71%8.60%
Upgrade
Buyback Yield / Dilution
-1.05%-1.05%-0.17%5.67%-308.70%-113.98%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q